Miss Sandra Morana Fernandez

Santiago De Compostela (Spain)

Follow

Contributor content

Empagliflozin treatment differentially modifies visceral and subcutaneous adipose tissue lipidomes and pro-inflammatory cytokines in zucker fatty diabetic rats.

Presentation

Empagliflozin treatment differentially modifies visceral and subcutaneous adipose tissue lipidomes and pro-inflammatory cytokines in zucker fatty diabetic rats.

ESC 365 is supported by

novartis

Explore sponsored resources